Company / Operating Income
PTC Therapeutics, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$866.9M
FY2025
5-year range
-$439.5M / $866.9M
FY2021-FY2025
Trend
+386.5%
vs FY2024
Sector context
#13 of 204
Health Care
What the data says
Operating Income changed +387% YoY in FY2025, a notable deviation from the 9-year average annual change of +16%.
Based on SEC 10-K filings.
$867M in FY2025. Top quartile in the Health Care sector.
Improved from -$440M to $867M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 204This company $866.9M Sector average $107.8M
▼
+704.6% above sector average
Key checks
Key Insights
- In FY2025, operating income increased 386.5% year-over-year.
- Ranks #13 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $866.9M | +386.5% |
| FY2024 | -$302.6M | +31.2% |
| FY2023 | -$439.5M | -1.8% |
| FY2022 | -$431.8M | -79.0% |
| FY2021 | -$241.2M | -108.5% |
| FY2020 | -$115.7M | +52.0% |
| FY2019 | -$241.2M | -108.5% |
| FY2018 | -$115.7M | -79.9% |
| FY2017 | -$64.3M | +51.3% |
| FY2016 | -$132.1M | +21.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026